MedTrace Logo

APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.

NCT02323724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-09-22

No results posted yet for this study

Summary

To determine the improvement in diagnosis of papillary carcinoma by detecting mutation V600E BRAF in retrospective cases with inconclusive cytologic diagnosis (categories III, IV and V of Bethesda System)

Conditions

  • Papillary Thyroid Carcinoma

Interventions

GENETIC

BRAF V600E mutation by pyrosequencing technique

Sponsors & Collaborators

  • Corporacion Parc Tauli

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02323724 on ClinicalTrials.gov